Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.54 |
| ▸ | THRB | P10828 | 2/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | ELANE | P08246 | 3/20 | 0.43 |
| ▸ | F2 | P00734 | 1/20 | 0.43 |
| ▸ | PLG | P00747 | 1/20 | 0.43 |
| ▸ | CTSG | P08311 | 1/20 | 0.43 |
| ▸ | CMA1 | P23946 | 1/20 | 0.43 |
| ▸ | CTRC | Q99895 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | GSK3A | P49840 | 2/20 | 0.42 |
| ▸ | GSK3B | P49841 | 2/20 | 0.42 |
| ▸ | EP300 | Q09472 | 1/20 | 0.42 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.41 |
| ▸ | MGLL | Q99685 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7469304 | 0.85 | POLB (0.55) | MAPTTHRBGAAPOLBTP53 | |
| SCHEMBL3774754 | 0.81 | MAPT (0.50) | MAPTTHRBGAAPOLBTP53 | |
| SCHEMBL8471742 | 0.78 | MAPT (0.41) | MAPTTHRBGAAPOLBTP53 | |
| SCHEMBL8523889 | 0.77 | POLB (0.47) | MAPTTHRBGAAPOLBTP53 | |
| SCHEMBL8421439 | 0.77 | PPARG (0.43) | MAPTTHRBGAAPOLBTP53 | |
| SCHEMBL8472109 | 0.77 | MAPT (0.42) | MAPTTHRBGAAPOLBTP53 | |
| SCHEMBL8472017 | 0.77 | POLB (0.45) | MAPTTHRBGAAPOLBTP53 | |
| Hydrochloric Acid SCHEMBL8505855 | 0.76 | PPARG (0.44) | MAPTTHRBGAAPOLBTP53 | |
| SCHEMBL3774750 | 0.76 | POLB (0.46) | MAPTTHRBGAAPOLBTP53 | |
| SCHEMBL8687366 | 0.76 | POLB (0.44) | MAPTTHRBGAAPOLBTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060052627-A1 | Novel modulators of the PPAR-type receptors and cosmetic/pharmaceutical compositions comprised thereof | GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) | 2006-03-09 | — | — | US | disclosed |
| EP-1332142-A1 | SODIUM SALTS OF 5-[4-[2-(N-METHYL-N-(2-PYRIDYL)AMINO)ETHOXY]B ENZYL]THIAZOLIDINE-2,4-DIONE | SmithKline Beecham p.l.c. (GB) | 2003-08-06 | — | — | EP | disclosed |
| WO-2002026735-A1 | SODIUM SALTS OF 5-'4-'2-(N-METHYL-N-(2-PYRIDYL)AMINO)ETHOXY]BENZYL]THIAZOLIDINE-2,4-DIONE | SMITHKLINE BEECHAM P.L.C. (GB) | 2002-04-04 | — | — | WO | disclosed |
| EP-0555249-A1 | THIAZOLIDINEDIONE DERIVATIVES | BEECHAM GROUP plc (GB) | 1993-08-18 | — | — | EP | disclosed |
| US-4725610-A | TREATMENT OF HYPERLIPEMIA AND DIABETES | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1988-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060052627-A1 | Novel modulators of the PPAR-type receptors and cosmetic/pharmaceutical compositions comprised thereof | PPARG, PPARD, PPARA | MAPT 3674/4885THRB 370/4885GAA 1389/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.